Diagnamed Holdings Corp. · CSE:DMED
Diagnamed — Investor Presentation (October 2025)
15 slides from Diagnamed's investor presentation, October 2025
Slide 1: Pioneering Canada's White Hydrogen Frontier
DiagnaMed Holdings Corp. Pioneering Canada’s White Hydrogen Frontier DiagnaMed Holdings Corp. – CSE: DMED | October 2025
Slide 2: Investment Highlights
Investment Highlights • First mover in Canada’s white hydrogen corridor positioned to define exploration and extraction standards. • Ontario discoveries > 2 000 ppm H₂ — early data confirming hydrogen-rich zones in Timiskaming District. • Collaboration with QIMC & INRS to expand regional hydrogen ma
Slide 3: About DiagnaMed
About DiagnaMed DiagnaMed Holdings Corp. is a Canadian clean-technology company pioneering the discovery and production of naturally occurring geologic (“white”) hydrogen. Our Mission To unlock a new source of sustainable energy directly from the Earth using advanced subsurface analytics and clean,
Slide 4: Ontario Exploration Program
Ontario Exploration Regional Focus Program Located in the Timiskaming District within the Témiscamingue–Timiskaming Graben, along the Ontario–Québec border. Geological structures: deep fault zones, iron-rich basement formations, and historic hydrocarbon traps all ideal for natural hydrogen generatio
Slide 5: Discovery Process & Analytics
Discovery Process & Analytics Integrated Exploration Approach • Combines soil-gas sampling, spectrometric analysis, and geospatial modelling to identify naturally occurring hydrogen. • Focus on iron-bearing basement rocks and deep-fault zones where hydrogen forms through water–rock reactions. Analyt
Slide 6: Field Data Summary 2025 Ontario Survey Results
Metric Result Total Samples Collected 456 Samples > 500 ppm H₂ 209 (≈ 46 %) Highest Recorded > 2 000 ppm H₂ Concentration Survey Completion Q3 2025 QIMC & INRS (field & Partnerships data support) Key Insights Field Data Summary • Consistent hydrogen anomalies across multiple transects. 2025 Ontario
Slide 7: Collaboration with QIMC & INRS
Collaboration with QIMC & INRS Strategic Technical Partnerships • QIMC (Québec Innovative Materials Corp.) provides regional geological expertise and access to key exploration zones. • INRS (Institut National de la Recherche Scientifique) contributes academic validation, geochemical analysis, and mo
Slide 8: First Nations Partnership (MOU)
Commitment to Partnership and Stewardship First Nations • Formal Memorandum of Understanding (MOU) signed with regional First Nations communities to ensure Partnership (MOU) inclusive participation and mutual benefit. • Collaboration model built around consultation, cultural respect, and local engag
Slide 9: ESG & Environmental Stewardship
ESG & Environmental Stewardship Sustainability at the Core • Low-Impact Exploration: Compact surface footprint and minimal land disturbance through portable survey equipment and existing access routes. • Water Conservation: Hydrogen sourced naturally from subsurface formations — no electrolysis or w
Slide 10: Unlocking Ontario's Geologic Potential
Unlocking Ontario’s Geologic • The global hydrogen market is projected to exceed USD $407 Potential DiagnaMed Driving the Next billion by 2050 (IEA), driven by net-zero commitments and Wave of Clean-Energy Innovation industrial decarbonization. • Demand growth expected across transportation, steel,
Slide 11: Peer Comparison
Industry Context • The white (natural) hydrogen exploration industry remains early-stage but is expanding rapidly in North America. Peer Comparison • Only a few public issuers have reported verified field data in Canada and the U.S. • DiagnaMed, QIMC, and QMET lead early discoveries within Canada’s
Slide 12: Timeline
2025 – Discovery & Field Verification • Completion of Ontario sampling programs. • Integration of INRS geospatial models and QIMC field data. • Identification of high-priority hydrogen anomaly zones (> 2 000 ppm H₂). 2026 – Exploration Drilling Timeline • Drill-site selection within the Timiskaming
Slide 13: Capital Structure (as of October 2025)
Exchange CSE: DMED Shares Outstanding (Basic) ≈ 109 million Reserved for Issuance ≈ 20.5 million (Options & Warrants) ≈ C$ 7 – 8 million (@ $0.07 Market Capitalization share price) Insider & Founder Ownership ≈ 12 – 15 % Public Float ≈ 85 – 88 % Debt Nil – fully equity-funded ≈ C$ 1.0 million (Q3 20
Slide 14: Leadership & Advisory
Leadership & Advisory Executive Team • John Karagiannidis, MBA, LL.B – CEO & President 25+ years in capital markets; completed 300+ transactions worth $2B+. Former Desjardins & Marquest Capital Markets. MBA (Ivey), LL.B (UdeM). • Edward Low – Interim Chief Financial Officer 20 years in finance; CFO
Slide 15: Contact Information
Contact Information DiagnaMed Holdings Corp. CSE: DMED Head Office Suite 2900, 550 Burrard Street Vancouver, British Columbia V6C 0A3, Canada Contact Details info@diagnamed.com 514-726-7058 www.diagnamed.com DiagnaMed Holdings Corp. – CSE: DMED | October 2025
DiagnaMed Holdings — Investor Presentation (October 2025) on 6ix